INDIA
NOT JUST STENTS: PRICE OF ALL DRUGS MUST BE CAPPED
PROVIDERS USING OTHER METHODS TO CLAIM HIGHER PROFITS
2018-02-10 12:01
-
The reduction in the coronary stent price by the National Pharmaceutical Pricing Authority (NPPA) on 13 February 2017 after a court order had been welcomed by the people. The price of life saving coronary stents was slashed by up to 85 per cent by capping them at Rs 7,260 for bare metal stents (BMS) and Rs 29,600 for drug eluting stents (DES). Earlier, the average maximum retail price (MRP) for BMS was Rs 45,000 and for DES, it was Rs 1.21 lakh. This was a big relief and exposed the loot by the companies, the health provider institutions and a section of the health professionals. Some of the patients have got real benefit of this reduction. In fact, this is not a reduction in sale price but the actual price has been brought forth by the National Pharmaceutical Pricing Authority (NPPA) and it has curbed excess charging.